This article looks at the approach that President-elect Trump and his HHS Secretary-nominee, Tom Price, may take in staffing FDA. Catalyst President Nancy Bradish Myers comments on the influence that a new FDA Commissioner-nominee will have; she also notes the importance of having a strong manager at the top of the agency, particularly at a time when the user fee agreements coming up in 2017 will include new funds for significant increases in hiring at the agency.
(Subscription required)